bioAffinity Technologies, Inc. (BIAF) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Physician offices and clinics ordering CyPath Lung growth | 155.00 percent | FY2026-Q2 |
| CyPath Lung unit sales growth | 300.00 percent | FY2026-Q2 |
Back to BIAF overview · BIAF earnings · BIAF holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.